HK1223288A1 - 用於口服施用的結合質子的聚合物 - Google Patents

用於口服施用的結合質子的聚合物

Info

Publication number
HK1223288A1
HK1223288A1 HK16111588.7A HK16111588A HK1223288A1 HK 1223288 A1 HK1223288 A1 HK 1223288A1 HK 16111588 A HK16111588 A HK 16111588A HK 1223288 A1 HK1223288 A1 HK 1223288A1
Authority
HK
Hong Kong
Prior art keywords
proton
oral administration
binding polymers
polymers
binding
Prior art date
Application number
HK16111588.7A
Other languages
English (en)
Inventor
Gerrit Klaerner
Eric F Connor
Randi K Gbur
Matthew J Kade
Paul H Kierstead
Jerry M Buysse
Michael J Cope
Kalpesh N Biyani
Son H Nguyen
Scott M Tabakman
Original Assignee
Tricida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tricida Inc filed Critical Tricida Inc
Publication of HK1223288A1 publication Critical patent/HK1223288A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/02Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/024Polyamines containing oxygen in the form of ether bonds in the main chain
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4077Concentrating samples by other techniques involving separation of suspended solids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4077Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4083Concentrating samples by other techniques involving separation of suspended solids sedimentation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4077Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088Concentrating samples by other techniques involving separation of suspended solids filtration
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
HK16111588.7A 2013-06-05 2016-10-05 用於口服施用的結合質子的聚合物 HK1223288A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05
PCT/US2014/041152 WO2014197725A1 (en) 2013-06-05 2014-06-05 Proton-binding polymers for oral administration

Publications (1)

Publication Number Publication Date
HK1223288A1 true HK1223288A1 (zh) 2017-07-28

Family

ID=51212941

Family Applications (3)

Application Number Title Priority Date Filing Date
HK16110308.8A HK1222120A1 (zh) 2013-06-05 2016-08-30 用於口服施用的結合質子的聚合物
HK16111588.7A HK1223288A1 (zh) 2013-06-05 2016-10-05 用於口服施用的結合質子的聚合物
HK18110550.1A HK1251151B (zh) 2013-06-05 2018-08-16 用於口服給藥的質子結合聚合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16110308.8A HK1222120A1 (zh) 2013-06-05 2016-08-30 用於口服施用的結合質子的聚合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18110550.1A HK1251151B (zh) 2013-06-05 2018-08-16 用於口服給藥的質子結合聚合物

Country Status (25)

Country Link
US (8) US9205107B2 (zh)
EP (4) EP3812761A1 (zh)
JP (4) JP6453860B2 (zh)
KR (4) KR102318910B1 (zh)
CN (3) CN105377270B (zh)
AU (3) AU2014274817B2 (zh)
BR (1) BR112015030142B1 (zh)
CA (1) CA2912911C (zh)
CY (3) CY1119611T1 (zh)
DK (3) DK3003327T3 (zh)
ES (3) ES2834485T3 (zh)
HK (3) HK1222120A1 (zh)
HR (3) HRP20171590T1 (zh)
HU (3) HUE051198T2 (zh)
IL (3) IL242758B (zh)
LT (3) LT3578185T (zh)
MX (3) MX364785B (zh)
NO (1) NO2905572T3 (zh)
PL (2) PL3003327T3 (zh)
PT (3) PT3003327T (zh)
RS (2) RS59033B1 (zh)
RU (1) RU2728778C2 (zh)
SI (3) SI3578185T1 (zh)
TR (1) TR201909355T4 (zh)
WO (1) WO2014197725A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE051198T2 (hu) 2013-06-05 2021-03-01 Tricida Inc Protonmegkötõ polimerek szájon át történõ beadására
ES2857177T3 (es) * 2014-12-10 2021-09-28 Tricida Inc Polímeros de unión de protones para administración oral
MA54925A (fr) * 2016-05-06 2021-12-22 Tricida Inc Compositions pour le traitement de troubles acido-basiques
AU2017388956A1 (en) 2016-12-28 2019-07-11 Fujifilm Corporation Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
CN111225674A (zh) 2017-10-16 2020-06-02 富士胶片株式会社 高磷血症治疗剂
AU2018360868A1 (en) * 2017-11-03 2020-04-30 Tricida, Inc. Method of treating acid-base disorders
AU2018360867A1 (en) * 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
EP3740201A4 (en) * 2018-06-04 2021-03-17 Tricida Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
EP3999593A1 (en) * 2019-07-19 2022-05-25 Acatechol, Inc. Molecularly well-defined antibiofouling and polyionic coatings
EP4053179A1 (en) 2021-03-01 2022-09-07 Tricida Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2023109825A1 (zh) * 2021-12-14 2023-06-22 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20230047972A (ko) 2023-03-21 2023-04-10 최문수 개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
EP0786993B1 (en) 1994-10-17 2002-06-05 Peter W. Stacpoole Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and their use in the treatment of metabolic and cardiovascular disorders
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
AU2682499A (en) 1998-02-17 1999-08-30 Dimitri R. Kioussis Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
WO2001066607A1 (fr) 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
AU2001241076A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
AU2001241095A1 (en) 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
MXPA03009571A (es) 2001-04-18 2004-02-12 Genzyme Corp Metodo para tratar la gota y unir el acido urico.
AU2002252632B2 (en) * 2001-04-18 2004-09-23 Genzyme Corporation Low salt forms of polyallylamine
JP2005519949A (ja) 2002-03-11 2005-07-07 ノバルティス アクチエンゲゼルシャフト ナテグリニドの塩
EP1597276A4 (en) 2003-02-10 2006-11-29 Autogen Res Pty Ltd THERAPEUTIC MOLECULES
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
WO2005065291A2 (en) 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
JPWO2005072773A1 (ja) 2004-01-29 2007-10-11 学校法人慶應義塾 赤血球機能修飾物質
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
KR101153035B1 (ko) 2004-03-30 2012-06-11 리립사, 인크. 이온 결합 조성물
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
JP2008506772A (ja) 2004-07-19 2008-03-06 エヌ.ブイ.・ヌートリシア ケトン体の調節のために、アスパラギン酸塩およびビタミンb12またはビオチンを使用するための製剤
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
EP1831266B1 (en) * 2004-10-13 2010-04-07 Ilypsa, Inc. Crosslinked amine polymers
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
AU2006264407B2 (en) 2005-07-04 2012-08-30 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
NZ566743A (en) 2005-08-18 2010-07-30 Globoasia Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
BRPI0616604A2 (pt) * 2005-09-30 2012-12-25 Ilypsa Inc mÉtodo para remover e composiÇço para seletivamente remover Íon de potÁssio do trato gastrintestinal de um mamÍfero, mÉtodo para seletivamente remover Íon de potÁssio de um meio-ambiente, composiÇço farmacÊutica, partÍcula de nécleo-envoltàrio, e, usos de uma partÍcula de nécleo-envoltàrio e de uma composiÇço farmacÊutica
WO2007038802A2 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
JP2009514966A (ja) 2005-11-08 2009-04-09 ジェンザイム・コーポレーション 高リン血症のためのマグネシウム含有重合体
CN101355953B (zh) 2005-11-08 2014-07-09 味之素株式会社 麻醉苏醒促进剂
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
EP2016114A2 (en) 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
JP2009542653A (ja) 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄(ii)含有治療剤
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
EP2049014A2 (en) * 2006-07-18 2009-04-22 Genzyme Corporation Amine dendrimers
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
WO2008016729A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
BRPI0717008A2 (pt) 2006-09-01 2014-01-21 Usv Ltd Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
WO2008027551A2 (en) * 2006-09-01 2008-03-06 Genzyme Corporation Dendrimer compositions
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
WO2008029949A1 (en) 2006-09-06 2008-03-13 Sucampo Ag Method and composition for promoting gastrointestinal bicarbonate secretion
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
WO2008109095A1 (en) 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
US20100166696A1 (en) 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
WO2009005838A2 (en) 2007-07-02 2009-01-08 Cognate3 Llc Process for the preparation of a non-corrosive base solution and methods of using same
WO2009008480A1 (ja) 2007-07-11 2009-01-15 Toray Industries, Inc. 架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
JP2011506449A (ja) 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
CA2732764C (en) 2008-03-11 2023-04-04 Livionex Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
KR20100133468A (ko) 2008-04-08 2010-12-21 유에스브이 리미티드 아민 폴리머 염의 제조 방법
ES2380162T3 (es) 2008-04-11 2012-05-09 Gp Investimenti S.R.L. Dispositivo de uso manual para el tratamiento de tejido humano con ultrasonidos
WO2009154747A1 (en) 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20100104527A1 (en) 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
WO2010022380A2 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
ES2891027T3 (es) 2008-09-25 2022-01-25 Vive Crop Prot Inc Procedimientos de producción de nanopartículas poliméricas y formulaciones de ingrediente activo
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
US20100113479A1 (en) 2008-10-30 2010-05-06 Anusuya Choudhury Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
RU2011134847A (ru) 2009-01-22 2013-02-27 Юсв Лимитед Фармацевтические композиции, содержащие фосфатсвязывающий полимер
CA2777682C (en) 2009-10-13 2015-02-24 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
US20120219626A1 (en) 2009-10-22 2012-08-30 Niels Jaap Osinga Pharmaceutical Compositions of Sevelamer
RU2012128509A (ru) 2009-12-07 2014-01-20 Айронвуд Фармасьютикалз, Инк. Способы лечения заболеваний желудочно-кишечного тракта
EP3130343B1 (en) 2010-02-24 2018-05-09 Relypsa, Inc. Polyimidazoles for use as bile acid sequestrants
BR112012021444A2 (pt) 2010-02-24 2016-05-31 Relypsa Inc polímero de amina reticulado, composição farmacêutica, método de redução do colesterol ldl sérico em um indivíduo, métodos para tratar doença, de remoção de sais biliares de um indivíduo, e para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de aminas.
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
EP3730136B1 (en) 2012-06-21 2023-12-27 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of chronic kidney disease patients
US10813946B2 (en) 2012-10-08 2020-10-27 Vifor (International) Ltd. Potassium binding polymers for treating hypertension and hyperkalemia
HUE051198T2 (hu) 2013-06-05 2021-03-01 Tricida Inc Protonmegkötõ polimerek szájon át történõ beadására
EA201690926A1 (ru) 2013-11-04 2016-09-30 Керикс Байофармасьютикалз, Инк. Цитрат железа (iii) для уменьшения сердечной недостаточности у пациентов с хроническим заболеванием почек
ES2857177T3 (es) 2014-12-10 2021-09-28 Tricida Inc Polímeros de unión de protones para administración oral
MA54925A (fr) 2016-05-06 2021-12-22 Tricida Inc Compositions pour le traitement de troubles acido-basiques
AU2018360867A1 (en) 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
AU2018360868A1 (en) 2017-11-03 2020-04-30 Tricida, Inc. Method of treating acid-base disorders
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
EP3740201A4 (en) 2018-06-04 2021-03-17 Tricida Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER

Also Published As

Publication number Publication date
ES2733493T3 (es) 2019-11-29
KR20240023672A (ko) 2024-02-22
AU2014274817A1 (en) 2015-12-24
US9205107B2 (en) 2015-12-08
RU2015155596A (ru) 2017-07-18
CN111671767A (zh) 2020-09-18
SI3287133T1 (sl) 2019-09-30
KR20210131457A (ko) 2021-11-02
SI3003327T1 (en) 2018-01-31
HRP20201767T1 (hr) 2020-12-25
HK1251151B (zh) 2020-04-24
IL271932A (en) 2020-02-27
PT3003327T (pt) 2017-11-09
LT3003327T (lt) 2017-12-27
JP6759316B2 (ja) 2020-09-23
KR102633597B1 (ko) 2024-02-06
BR112015030142A2 (pt) 2017-07-25
HUE051198T2 (hu) 2021-03-01
US11197887B2 (en) 2021-12-14
TR201909355T4 (tr) 2019-07-22
PL3287133T3 (pl) 2019-10-31
JP2022107004A (ja) 2022-07-20
AU2019275584A1 (en) 2020-01-02
CY1119611T1 (el) 2018-04-04
US20200206260A1 (en) 2020-07-02
CN111671767B (zh) 2024-03-08
DK3003327T3 (en) 2017-10-23
CN105377270A (zh) 2016-03-02
EP3578185A1 (en) 2019-12-11
BR112015030142B1 (pt) 2023-03-07
RU2015155596A3 (zh) 2018-05-10
US20180280428A1 (en) 2018-10-04
US20190134075A1 (en) 2019-05-09
IL271932B (en) 2020-11-30
HK1222120A1 (zh) 2017-06-23
HUE034836T2 (en) 2018-03-28
HRP20171590T1 (hr) 2017-12-29
EP3287133A1 (en) 2018-02-28
EP3003327A1 (en) 2016-04-13
MX2019005300A (es) 2019-08-12
RS61005B1 (sr) 2020-11-30
DK3578185T3 (da) 2020-11-02
AU2019219800B1 (en) 2019-09-19
US10369169B1 (en) 2019-08-06
PT3578185T (pt) 2020-11-10
IL242758B (en) 2020-01-30
MX2021013880A (es) 2022-06-02
JP2020203917A (ja) 2020-12-24
JP6453860B2 (ja) 2019-01-16
LT3578185T (lt) 2020-11-25
KR20230114326A (ko) 2023-08-01
RU2728778C2 (ru) 2020-07-31
LT3287133T (lt) 2019-07-10
EP3287133B1 (en) 2019-04-17
JP2016520652A (ja) 2016-07-14
KR102318910B1 (ko) 2021-10-29
ES2646271T3 (es) 2017-12-13
US9993500B2 (en) 2018-06-12
JP7075455B2 (ja) 2022-05-25
WO2014197725A1 (en) 2014-12-11
IL278183B (en) 2021-09-30
CY1121801T1 (el) 2020-07-31
NO2905572T3 (zh) 2017-12-16
DK3287133T3 (da) 2019-07-01
RS59033B1 (sr) 2019-08-30
EP3578185B1 (en) 2020-08-05
EP3812761A1 (en) 2021-04-28
CY1123673T1 (el) 2022-03-24
CN111671766A (zh) 2020-09-18
AU2019275584B2 (en) 2021-10-21
US20150056451A1 (en) 2015-02-26
MX364785B (es) 2019-05-07
US20220096534A1 (en) 2022-03-31
ES2834485T3 (es) 2021-06-17
AU2014274817B2 (en) 2019-05-23
KR20160041855A (ko) 2016-04-18
CA2912911A1 (en) 2014-12-11
CA2912911C (en) 2023-10-03
SI3578185T1 (sl) 2021-01-29
HUE043999T2 (hu) 2019-09-30
MX2015016527A (es) 2016-07-22
US10363268B2 (en) 2019-07-30
US20160074430A1 (en) 2016-03-17
PL3003327T3 (pl) 2018-02-28
EP3003327B1 (en) 2017-08-09
JP2019065024A (ja) 2019-04-25
CN111671766B (zh) 2024-03-08
HRP20191074T1 (hr) 2019-09-20
CN105377270B (zh) 2020-09-04
US20180015121A1 (en) 2018-01-18
IL278183A (en) 2020-11-30
US9925214B2 (en) 2018-03-27
PT3287133T (pt) 2019-07-12
US20190231812A1 (en) 2019-08-01
US10391118B2 (en) 2019-08-27

Similar Documents

Publication Publication Date Title
IL278183B (en) Proton binding polymers for oral administration
IL246377A0 (en) Pharmaceutical preparations for oral administration
HRP20180684T1 (hr) Kombinacija lijekova
IL290729A (en) Proton binding polymers for oral administration
GB201305103D0 (en) An oral dosage form
GB2520315B (en) Oral Syringes
GB201316662D0 (en) Pharmaceutical Combination
GB201309971D0 (en) Oral medicines syringe